Keywords:
Drug resistance in microorganisms
;
Drug Resistance, Microbial
;
Infectious Diseases
;
Microbiology
;
Bacteriology
;
Hospital Care
;
Parasitology
;
Preventive Medicine
;
Public Health
;
Aufsatzsammlung
;
Antimikrobieller Wirkstoff
;
Arzneimittelresistenz
Description / Table of Contents:
Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.Each chapter provides essential background and examines the evidence for an important aspect of prevention and control, treatment strategy or policy decision. Prevention and control strategies are analyzed for inappropriate antimicrobial use, fluoroquinolone-resistant organisms, health-care associated infections and parasitic diseases. Furthermore, treatment strategies for changing resistance patterns are explored for community-acquired pneumonia during an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase producing organisms and fungi. Data for policy making are presented in articles that detail the costs of antimicrobial-resistant infections in healthcare settings and the threat of resistance with the introduction of antiretroviral therapy for large populations in the developing world. These reviews show where interventions, surveillance and research will be most useful in the future. Antimicrobial Resistance is an invaluable contribution for infectious disease physicians and public health officials who are interested in the prevention of antimicrobial-resistant infections
Type of Medium:
Online Resource
Pages:
Online-Ressource (X + 174 S)
Edition:
Karger eBooks Collection
ISBN:
9783805593236
,
9783805593243
,
1283153580
,
9781283153584
Series Statement:
Issues in infectious diseases 6
URL:
https://karger.com/books/book/2681
URL:
http://dx.doi.org/10.1159/isbn.978-3-8055-9324-3
URL:
http://d-nb.info/997752181/04
DDC:
616.9041
Language:
English
Note:
When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
,
Cover; Contents; Foreword; Preface; Community-Associated Methicillin Resistant Staphylococcus aureus; Abstract; S. aureus, MRSA and Community-Associated Infections: Background; Rapid Increase in CA-MRSA Incidence; Risk Factors, Clinical Manifestations and Transmission; Differences between CA-MRSA and HA-MRSA; Molecular Epidemiology of CA-MRSA; Staphylococcal Chromosomal Cassette-Type Element; Pathogenesis of CA-MRSA Infecti; Virulence Factors; Diagnosis; Treatment; Prevention; References; Infections with Organisms Producing Extended-Spectrum β-Lactamase; Abstract; Introduction
,
Host Range and Prevalence of ESBLsRisk Factors for Colonization and Infection with Hospital-Acquired ESBL Producers; Risk Factors for Colonization and Infection with Health Care-Associated ESBL Producers; Infection Control and ESBL-Producing Organisms; Laboratory Detection of ESBL Production by Gram-Negative Bacilli; Treatment of Infection with ESBL-Producing Organisms; Conclusions; References; Fluoroquinolone Resistance: Challenges for Disease Control; Abstract; Mechanisms of Resistance; Detection of Resistance in the Clinical Laboratory; Prevalence of Resistance in Selected Pathogens
,
Therapeutic and Public Health Implications of ResistanceDrivers of Resistance; Conclusion; References; Antibiotic Resistance and Community-Acquired Pneumonia during an Influenza Pandemic; Abstract; Epidemiology of Bacterial Community-Acquired Pneumonia During Inter-Pandemic Periods in the United States; Biological Mechanisms for Interactions Between Influenza and Bacterial CAP; Epidemiologic Evidence That Influenza Increases the Risk of Bacterial CAP; Relationship Between Past and Future Pandemics; Strategies for Reducing Secondary Pneumonia Caused by Resistant Bacteria during a Pandemic
,
Future DirectionsAcknowledgments; References; Promoting Appropriate Antimicrobial Drug Use in the Outpatient Setting: What Works?; Abstract; Trends in Outpatient Antimicrobial Utilization; Interventions to Improve Outpatient Antimicrobial Use; Clinical Decision Support to Improve Antimicrobial Prescribing; Health Plan Performance Measures to Promote Improved Prescribing; AHRQ Analysis of Quality Improvement Strategies for Antimicrobial Prescribing; Doctor-Patient Communication and Its Influence on Antimicrobial Prescribing; Future Directions; References
,
Reducing Antimicrobial-Resistant Infections in Health Care Settings: What Works?Abstract; Overview; Antibiotic Control; Infection-Control Practices; Isolation Precautions; Prevention of Infection to Prevent Resistance; Future Approaches; References; Cost of Antimicrobial Resistance in Healthcare Settings: A Critical Review; Abstract; Global Estimates of Cost; Perspective; Literature Review; Methodological Issues; Cost of Prevention; Future Directions; References; Mass Treatment of Parasitic Disease: Implications for the Development and Spread of Anthelmintic Resistance; Abstract
,
Mass Treatment of Parasitic Disease
Permalink
